logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Scientia Raises $50M Growth Equity Investment From Vivo Capital

Scientia Raises $50M Growth Equity Investment From Vivo Capital

05/27/21, 4:56 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsalt lake
Money raised
$50 million
Scientia Vascular (“Scientia” or the “Company”), a rapidly growing commercial company focused on helping save patients’ lives with a suite of interventional medical devices, has raised $50M of growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology.

Company Info

Company
Scientia
Location
salt lake, utah, united states
Additional Info
Scientia is a pioneer in microfabrication technology and the company has used their core expertise to create a suite of commercially available and pipeline products for the treatment of neurovascular disease, peripheral vascular disease and interventional oncology. The company designs, develops and manufactures from its headquarters and ISO 14385 facility in Salt Lake City, Utah.
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.